Oligo Security

Cybersecurity Dual-Use Technology Priority Signal Founded 2022

Last updated: Jul 31, 2026

Oligo Security provides runtime-native application and cloud security that observes what code, dependencies, models, and agents actually execute in production. It uses that execution context to prioritize exploitable vulnerabilities, detect malicious behavior, and support response across modern and legacy workloads.

Visit Website

Company Overview

Oligo's core product is a runtime security platform built around Deep Application Inspection and lightweight sensors. Rather than treating every package named in an SBOM or static scan as equally exposed, the platform correlates live execution with vulnerable functions, call stacks, processes, application behavior, and workload context. Its stated outputs include runtime SBOM and VEX evidence, function-level vulnerability enrichment, exploit detection, malicious-package detection, and policy-based response. The company has also expanded the platform into Cloud Application Detection and Response (CADR) and runtime AI security, including visibility and response for models and agents. These extensions are strategically coherent with the original runtime thesis, but they also raise the question of whether the product is becoming a broad security platform faster than its category and sales motion can support.

The customer problem is a persistent weakness in software-security operations: SCA, SBOM, CSPM, and CNAPP tools can generate large volumes of theoretical exposure, while engineering teams need to know which code paths are loaded, reachable, and exploitable in a live environment. Oligo's value proposition is to reduce that uncertainty and connect security findings to remediation or containment decisions. The likely buyers span application-security, cloud-security, vulnerability-management, and SOC teams, which creates multiple budget paths but also complicates ownership. The platform is relevant to cloud-native microservices as well as Java and other legacy applications where immediate patching may be disruptive. Public product material claims low resource overhead and large reductions in vulnerability noise; those claims should be tested with customer telemetry and independent validation rather than accepted at face value.

Commercial signals are stronger than the prior seed-stage record suggested. Oligo publicly announced a $28 million financing at launch in 2023, and reputable reporting described a $50 million Series B in January 2025, implying roughly $80 million of disclosed financing. The company's own site now describes adoption by Fortune 500 organizations and lists named customer testimonials, while its 2025 and 2026 product announcements show continued investment in CADR, AI-SPM, AI detection and response, vulnerability intelligence, and compliance evidence. These are useful traction indicators, not proof of durable retention, revenue scale, or category leadership. Diligence should seek cohort retention, deployment-to-expansion data, sensor coverage by language and runtime, false-negative rates, and evidence that runtime findings change patching or incident outcomes.

Competition is broad and increasingly convergent. Contrast Security and other runtime application-security specialists compete for application visibility and protection; Snyk and Endor Labs compete for software-composition analysis, reachability, and developer workflow; Wiz, Palo Alto Networks, Aqua Security, and Sysdig can bundle adjacent cloud and workload controls. Oligo can differentiate if its function-level execution evidence is more precise, lower friction, and more actionable than metadata-driven alternatives, especially when a buyer needs to prioritize a large backlog or protect an unpatchable dependency. That edge is not guaranteed: platform vendors can add runtime context, and standalone tools must prove that their sensor provides enough incremental value to justify another agent, integration, and procurement decision.

The dual-use case is credible but conditional. Defense, aerospace, government, and critical-infrastructure operators also depend on open-source components, third-party libraries, cloud workloads, and increasingly AI-enabled systems; runtime proof can help them manage patch windows, legacy software, and software-supply-chain exposure. Runtime blocking and forensic context could be relevant to mission-support applications and sensitive enterprise estates. However, no public evidence reviewed here establishes a defense contract, classified deployment, or full government authorization. The strategic case therefore depends on demonstrated operation in restricted or on-prem environments, auditable telemetry, secure update mechanisms, support for disconnected networks, and a response model that does not create unacceptable availability risk.

Dual-Use Assessment

Military & Commercial Applications

Oligo's runtime observation and response technology has substantive commercial and security applicability because defense and critical-infrastructure software estates face the same dependency and workload risks as commercial environments, often with longer patch cycles and more legacy code. The thesis remains conditional: public evidence does not establish defense contracts or classified use, so restricted-network support, auditability, secure updates, and availability-safe enforcement require diligence.

Strategic Fit Assessment

Research priority signal

Priority signal means this entry may be worth researching within the Claw & Talon thesis. It does not mean investable, suitable, endorsed, available, or likely to produce returns.

Oligo has a credible strategic fit with a dual-use software-assurance thesis: a technically differentiated runtime signal can make vulnerability backlogs more actionable across AppSec, cloud, and SOC teams, while its application to legacy and AI workloads expands relevance. The Series B and continued product expansion are meaningful maturity signals, but not substitutes for diligence on recurring revenue, retention, sensor performance, deployment friction, and competitive win rates. The principal question is whether execution-level evidence remains a durable product advantage as CNAPP and AppSec suites converge.

Strategic Value to U.S.-Israel Alliance

The company's strategic value lies in turning software inventory and vulnerability data into observed runtime exposure and response context. That can improve resilience for sensitive applications, supply chains, and AI-enabled systems where patching is slow or incomplete. Oligo becomes more relevant to national-security and critical-infrastructure users if it can operate with minimal overhead in on-prem or restricted environments, produce auditable evidence, and enforce policies safely; those capabilities should be verified rather than inferred from commercial marketing.

Key Technologies

  • Deep Application Inspection for function-level execution and exploit context
  • Kernel-safe or lightweight runtime sensors for applications, containers, and workloads
  • Runtime SBOM and VEX generation tied to observed behavior
  • Vulnerable-function enrichment and reachability analysis beyond CVE package metadata
  • Cloud Application Detection and Response with application-to-workload attack context
  • Behavioral detection for malicious packages, exploits, AI models, and agents
  • Runtime policy enforcement, blocking, and SOC/AppSec workflow integrations

Use Cases & Applications

  • Prioritize SCA findings by the vulnerable functions and dependencies actually executed in production
  • Generate runtime SBOM and VEX evidence for vulnerability management and compliance workflows
  • Detect and contain exploitation, dependency hijacking, and malicious package behavior in live workloads
  • Investigate incidents using application-layer call stacks, process trees, and end-to-end attack context
  • Protect cloud-native microservices and Kubernetes workloads without relying only on build-time scans
  • Reduce exposure from legacy Java and other difficult-to-patch third-party components
  • Monitor AI models and agents for prompt injection, unsafe behavior, and anomalous tool activity
  • Support software assurance in regulated, defense-adjacent, and critical-infrastructure environments

Sources and verification

This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work.

This record lists 7 public references used for company identity, status, positioning, or material-claim review.

Public sources

The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.

  • oligo.security Public source used for profile verification.
  • oligo.security Public source used for profile verification.
  • oligo.security Public source used for profile verification.
  • oligo.security Public source used for profile verification.
  • oligo.security Public source used for profile verification.
  • axios.com Public source used for profile verification.
  • calcalistech.com Public source used for profile verification.
  • Profile update timestamp Last updated in the Claw & Talon database on Jul 31, 2026.

Investor Lens

What this entry is

Private startup

Why it may matter

Oligo Security may matter as a Cybersecurity entry with not currently an investable standalone company for Israeli technology research.

How an independent investor should read this

Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.

Evidence to verify

  • Verify current status
  • Verify traction
  • Verify cap table/funding
  • Verify technical claims
  • Verify regulatory/export-control issues
  • Verify customer concentration

Main investor questions

  • Is the company currently active, independently financeable, and raising or not raising on terms you can verify?
  • What customer, revenue, product, and technical evidence supports the company story?
  • What valuation, cap table, rights, and follow-on assumptions would govern any private exposure?
  • Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
  • What evidence would change the thesis or show that the profile is stale?

What not to infer

  • Inclusion does not imply endorsement.
  • Inclusion does not imply allocation availability or current fundraising.
  • Scores do not indicate investment suitability or expected returns.
  • Strategic importance does not automatically imply venture return potential.

Diligence questions

  • What evidence verifies Oligo Security's current customer traction, deployment status, and revenue concentration?
  • Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
  • Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
  • How does the platform integrate into existing SOC, cloud, identity, or compliance workflows without adding operational burden?
  • What would disconfirm the priority signal: weak customer references, thin technical differentiation, poor capital efficiency, or limited allied-market access?

Related sector

See the Cybersecurity sector page for market context, related subcategories, and other Israeli companies in this part of the database.

Need a diligence readout?

Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.